Grace Therapeutics (GRCE) Exchange Rate Effect (2019 - 2023)
Grace Therapeutics' (GRCE) quarterly Exchange Rate Effect came in at -$134000.0 in Q1 2023, down 151.94% year-over-year from $258000.0 in Q1 2022, and down 144.08% quarter-over-quarter from $304000.0 in Q4 2022.
Powered by 
Analysis
Grace Therapeutics (GRCE) Exchange Rate Effect (2019 - 2023) Analysis & Trends
Grace Therapeutics has disclosed Exchange Rate Effect across 5 years of filings, most recently posting -$134000.0 for Q1 2023.
- In Q1 2023, Exchange Rate Effect fell 151.94% year-over-year to -$134000.0; the TTM figure through Dec 2022 stood at $392000.0 (up 104.58% YoY), while the FY2022 annual figure was $127000.0, up 102.57% from the prior year.
- Exchange Rate Effect came in at -$134000.0 for Q1 2023 at Grace Therapeutics, down from $304000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.7 million in Q4 2020 to a low of -$8.4 million in Q1 2021.
- Average Exchange Rate Effect over 5 years is -$290937.5, with a median of $144500.0 recorded in 2020.
- Year-over-year, Exchange Rate Effect slumped 3217.72% in 2021 and jumped 1316.0% in 2022.
- Over 5 years, Exchange Rate Effect stood at $345000.0 in 2019, then jumped by 676.23% to $2.7 million in 2020, then tumbled by 100.93% to -$25000.0 in 2021, then jumped by 1316.0% to $304000.0 in 2022, then tumbled by 144.08% to -$134000.0 in 2023.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$134000.0 in Q1 2023, $304000.0 in Q4 2022, and -$221000.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | -84,000.00 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Grace Therapeutics | 39.38 Mn | 39.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -134,000.00 |
| Dec 31, 2022 | 304,000.00 |
| Sep 30, 2022 | -221,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 258,000.00 |
| Dec 31, 2021 | -25,000.00 |
| Sep 30, 2021 | -978,000.00 |
| Jun 30, 2021 | 872,000.00 |
| Mar 31, 2021 | -8.43 Mn |
| Dec 31, 2020 | 2.68 Mn |
| Sep 30, 2020 | 238,000.00 |
| Jun 30, 2020 | 572,000.00 |
| Mar 31, 2020 | -254,000.00 |
| Dec 31, 2019 | 345,000.00 |
| Sep 30, 2019 | -190,000.00 |
| Jun 30, 2019 | 256,000.00 |